![]() |
Oh my, the shorts never can get their arms around this Cummins (CMI - commentary - Cramer's Take), can they? This is one, correctly identified by Bob Marcin in these pages, that can't be contained.
At one point I questioned whether I really wanted to do Cummins just because I wanted to sit on an engine! But the truth was, even after the run, the analysts all hated it and you can never go wrong when, after a run, the negative people stay negative. If you don't agree with me, look at how the Schering-Ploughs (SGP - commentary - Cramer's Take) and Mercks (MRK - commentary - Cramer's Take) have picked up adherents even as they are up so much! Now the stock is up 24 points. Two weeks, 24 points. Outrageous. Cummins is unique in that it has an unassailable franchise that is recognized worldwide. (Earlier I talked about how Kubota (KUB - commentary - Cramer's Take) might be next for re-valuation, but the franchise is anything but unassailable and the dollar is going against it.) Cummins also was the company that was supposed to be so crushed by the pullthrough of orders into 2006 with changed emission standards. Our companies are better than that. Cummins is better than that. Hence the ramp. It isn't finished. We need the upgrades! And they will come very soon. Random musings: The hated stay hated aggressively in this market. Capital One (COF - commentary - Cramer's Take) misses, a bad miss, and there is no bottom. This business must be worth something to someone! ... Yahoo! (YHOO - commentary - Cramer's Take) finally bottomed because the percentage decline got absurd. ... Apple (AAPL - commentary - Cramer's Take), my pick on last Friday's show because it is the last "bad" quarter ahead of the iPhone, has room to run. ... I think the Under Armour (UA - commentary - Cramer's Take) piece in BusinessWeek was too negative. ... KBR's (KBR - commentary - Cramer's Take) way too hated vs. ABB (ABB - commentary - Cramer's Take), Foster Wheeler (FWLT - commentary - Cramer's Take) and Shaw (SGR - commentary - Cramer's Take). ... EMC (EMC - commentary - Cramer's Take) and Oracle (ORCL - commentary - Cramer's Take) seem like the only investible techs now that the chatter is anti-Cisco (CSCO - commentary - Cramer's Take) (chatter I don't believe in, but seasonably anything's possible in this negative moment). ... Has AstraZeneca (AZN - commentary - Cramer's Take) lost its mind? I don't see the reason for the overpay for MedImmune (MEDI - commentary - Cramer's Take). At the time of publication, Cramer was long Capital One and Yahoo!.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click here to order his book, "Real Money: Sane Investing in an Insane World," click here to get his second book, "You Got Screwed!" and click here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by clicking here. TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com. Brokerage Partners
|
|||||||||||||||||||||||||||||||||||||||